J L Hans Severens - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Plos One|July 25, 2019

Disutility associated with cancer screening programs: A systematic reviewLin Li, J L Hans Severens, Olena Mandrik

International Journal of Cancer|February 15, 2019

Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screeningOlena Mandrik, Nadine Zielonke, Filip Meheus, et al.

Open Medicine (Warsaw, Poland)|March 30, 2017

Cost comparison of treating chronic hepatitis C genotype one with pegylated interferons in UkraineOlena Mandrik, Saskia Knies, Olha Golubovska, et al.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013

Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task forceLouis P Garrison, Adrian Towse, Andrew Briggs, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Plos One|July 25, 2019

Disutility associated with cancer screening programs: A systematic reviewLin Li, J L Hans Severens, Olena Mandrik

International Journal of Cancer|February 15, 2019

Systematic reviews as a 'lens of evidence': Determinants of benefits and harms of breast cancer screeningOlena Mandrik, Nadine Zielonke, Filip Meheus, et al.

Open Medicine (Warsaw, Poland)|March 30, 2017

Cost comparison of treating chronic hepatitis C genotype one with pegylated interferons in UkraineOlena Mandrik, Saskia Knies, Olha Golubovska, et al.

Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 17, 2013

Performance-based risk-sharing arrangements-good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing arrangements task forceLouis P Garrison, Adrian Towse, Andrew Briggs, et al.

Pageof 1